Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mirna Therapeutics, Inc. | 3,696,662 | reported | 20 Apr 2021 | tx 7+2,436,666 |
| Nabriva Therapeutics Plc | 1,677,940 | reported | 23 Jun 2017 | tx 3+3,929,700 |
| Whitehawk Therapeutics, Inc. | 21,400 | reported | 18 Jun 2019 | tx 4+1,583,295 |
| Galecto, Inc. | 18,000 | reported | 14 Jun 2023 | tx 21+3,866,255−1,462,394 |
| Fusion Pharmaceuticals Inc. | 17,000 | reported | 14 Jun 2023 | tx 11+9,544,265−11,878,051 |
| Otonomy, Inc. | 15,000 | reported | 21 Jun 2016 | tx 16+2,286,398−2,490,827 |
| NextCure, Inc. | 14,250 | reported | 22 Jun 2023 | tx 14+2,790,013−18,967,921 |
| PALVELLA THERAPEUTICS, INC. | 6,115 | reported | 25 Oct 2017 | tx 14+625,973 |
| Inspire Medical Systems, Inc. | 1,875 | reported | 09 Oct 2020 | tx 38+2,471,462−15,254,341 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jun 2023 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |
| 11 Nov 2022 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 42,093 | 2.38 USD | |
| 23 Jun 2022 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 17 Nov 2021 | GRANT_AWARD | Galecto, Inc. | 9,000 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 20 Apr 2021 | GRANT_AWARD | Mirna Therapeutics, Inc. | 1,666,666 | 3.00 USD | |
| 02 Nov 2020 | PURCHASE | Galecto, Inc. | 209,500 | 15.00 USD | |
| 02 Nov 2020 | PURCHASE | Galecto, Inc. | 523,833 | 15.00 USD | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 2,055,824 | — | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 191,787 | — | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 822,311 | — | |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 73,773 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 291,999 | — | deriv |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 148,395 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 148,395 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 73,773 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 59,350 | — | deriv |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 59,350 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 31,147 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 02 Jun 2020.